294 related articles for article (PubMed ID: 29865931)
21. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
Mitchell AP; Winn AN; Lund JL; Dusetzina SB
Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
[TBL] [Abstract][Full Text] [Related]
22. Industry Payments to Physicians for Opioid Products, 2013-2015.
Hadland SE; Krieger MS; Marshall BDL
Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
[TBL] [Abstract][Full Text] [Related]
23. Effect of physician payment disclosure laws on prescribing.
Pham-Kanter G; Alexander GC; Nair K
Arch Intern Med; 2012 May; 172(10):819-21. PubMed ID: 22636826
[No Abstract] [Full Text] [Related]
24. The subtle nuances of intranasal corticosteroids.
Fowler J; Rotenberg BW; Sowerby LJ
J Otolaryngol Head Neck Surg; 2021 Mar; 50(1):18. PubMed ID: 33731223
[TBL] [Abstract][Full Text] [Related]
25. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
McCarthy M
BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
[No Abstract] [Full Text] [Related]
26. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea.
Hurley MP; Stafford RS; Lane AT
JAMA Dermatol; 2014 May; 150(5):487-93. PubMed ID: 24740450
[TBL] [Abstract][Full Text] [Related]
27. Industry payments and physicians prescriptions: Effect of a payment restriction policy.
Ansari B
Soc Sci Med; 2021 Jun; 278():113942. PubMed ID: 33892242
[TBL] [Abstract][Full Text] [Related]
28. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
[TBL] [Abstract][Full Text] [Related]
29. Association of Pharmaceutical Industry Payments to Physicians With Prescription and Medicare Expenditures for Pimavanserin.
Mehta HB; Moore TJ; Alexander GC
Psychiatr Serv; 2021 Jan; 72(1):77-80. PubMed ID: 32838675
[TBL] [Abstract][Full Text] [Related]
30. Cross-sectional Analysis of the Relationship between Paranasal Sinus Balloon Catheter Dilations and Industry Payments among Otolaryngologists.
Fujiwara RJT; Shih AF; Mehra S
Otolaryngol Head Neck Surg; 2017 Nov; 157(5):880-886. PubMed ID: 28895455
[TBL] [Abstract][Full Text] [Related]
31. Academic Influence and Its Relationship to Industry Payments in Orthopaedic Surgery.
Buerba RA; Sheppard WL; Herndon KE; Gajewski N; Patel AD; Leong NL; Bernthal NM; SooHoo NF
J Bone Joint Surg Am; 2018 May; 100(9):e59. PubMed ID: 29715232
[TBL] [Abstract][Full Text] [Related]
32. Nonresearch Industry Payments to Radiologists: Characteristics and Associations With Regional Medical Imaging Utilization.
Kokabi N; Junn JC; Xing M; Hemingway J; Hughes DR; Duszak R
J Am Coll Radiol; 2017 Mar; 14(3):418-425.e2. PubMed ID: 28082155
[TBL] [Abstract][Full Text] [Related]
33. Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies.
Hollenbeck BK; Oerline M; Kaufman SR; Caram MEV; Dusetzina SB; Ryan AM; Shahinian VB
Urology; 2021 Feb; 148():134-140. PubMed ID: 33075381
[TBL] [Abstract][Full Text] [Related]
34. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
Fickweiler F; Fickweiler W; Urbach E
BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
[TBL] [Abstract][Full Text] [Related]
35. The role of industry influence in sinus balloon dilation: Trends over time.
Gadkaree SK; Rathi VK; Gottschalk E; Feng AL; Phillips KM; Scangas GA; Metson R
Laryngoscope; 2018 Jul; 128(7):1540-1545. PubMed ID: 29737532
[TBL] [Abstract][Full Text] [Related]
36. The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications.
Modi PK; Wang Y; Kirk PS; Dupree JM; Singer EA; Chang SL
Urology; 2018 Jul; 117():50-56. PubMed ID: 29680480
[TBL] [Abstract][Full Text] [Related]
37. Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.
Brunt CS
Health Serv Res; 2019 Jun; 54(3):636-649. PubMed ID: 30273976
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.
Nusrat S; Syed T; Nusrat S; Chen S; Chen WJ; Bielefeldt K
JAMA Netw Open; 2018 Dec; 1(8):e186343. PubMed ID: 30646328
[TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
Mitchell AP; Winn AN; Dusetzina SB
JAMA Intern Med; 2018 Jun; 178(6):854-856. PubMed ID: 29630687
[TBL] [Abstract][Full Text] [Related]
40. Olopatadine/mometasone (Ryaltris) for allergic rhinitis.
Med Lett Drugs Ther; 2023 Jan; 65(1668):12-14. PubMed ID: 36651792
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
